BUY MBP REGORAFENIB RESIHANCE 40MG TAB TAB BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Regorafenib is an oral targeted cancer medicine used to treat certain advanced cancers, most commonly colorectal cancer, gastrointestinal stromal tumours, and hepatocellular carcinoma. Regorafenib is usually prescribed when other treatments have stopped working or are no longer suitable. If you have been prescribed regorafenib, it means your oncology team believes regorafenib may help slow the progression of your cancer and maintain disease control.

Regorafenib works by blocking multiple signalling pathways that cancer cells use to grow, survive, and form new blood vessels. Cancer needs a blood supply to continue growing. Regorafenib reduces blood vessel formation to the tumour and interferes with growth signals inside cancer cells. Regorafenib does not cure cancer, but regorafenib can slow tumour growth and help stabilise the disease for a period of time.

Regorafenib is taken by mouth once daily for 21 consecutive days, followed by 7 days off treatment. This 28-day cycle is repeated as long as regorafenib continues to work and side effects remain manageable. Regorafenib must be taken with a low-fat meal, as this helps ensure predictable absorption and reduces side effects. Swallow regorafenib tablets whole with water. Do not crush, chew, or split regorafenib tablets. Try to take regorafenib at the same time each day during the treatment days.

It is very important not to change the dose or stop regorafenib on your own. Dose reductions, pauses, or schedule changes are common with regorafenib and are part of safe treatment, but these decisions must be made by your doctor.

Now let?s talk about what to expect while taking regorafenib.

One of the most common and clinically important side effects of regorafenib is hand-foot skin reaction. This affects the palms of the hands and the soles of the feet. You may notice redness, swelling, pain, tingling, thickened skin, or blistering. This usually occurs early in regorafenib treatment. Early reporting is essential. Regular use of moisturisers, avoiding friction and pressure, wearing well-cushioned footwear, and avoiding heat can help reduce severity. If hand-foot symptoms worsen, your doctor may adjust the regorafenib dose.

Skin reactions elsewhere on the body are also common with regorafenib. These include rash, dryness, peeling, and itching. Gentle skin care and sun protection are important throughout regorafenib treatment.

Fatigue is very common with regorafenib. This may feel like ongoing tiredness that does not fully improve with rest. Fatigue can accumulate over treatment cycles. Pacing daily activities and prioritising rest is important. Sudden or severe fatigue should be reported.

Regorafenib frequently causes high blood pressure, particularly early in treatment. Blood pressure is monitored regularly. You should report headaches, dizziness, visual changes, chest discomfort, or shortness of breath promptly, as these may be signs of elevated blood pressure.

Regorafenib can significantly affect liver function. This is one of the most serious risks of regorafenib. Blood tests are performed regularly, especially in the first two months of treatment. Seek urgent medical attention if you notice yellowing of the skin or eyes, dark urine, severe nausea, vomiting, abdominal pain, or unusual fatigue, as these may indicate liver injury.

Gastrointestinal side effects are common with regorafenib. These include diarrhoea, reduced appetite, nausea, abdominal discomfort, and weight loss. Staying well hydrated is important. Diarrhoea should be reported early so it can be treated before it becomes severe.

Regorafenib can increase the risk of bleeding. This risk is higher in people with liver disease or those taking blood-thinning medicines. Seek urgent medical attention if you notice black stools, blood in the urine, vomiting blood, coughing up blood, or unusual bruising.

Mouth soreness, hoarseness, or throat irritation can occur with regorafenib. Good oral hygiene and avoiding irritating foods can help. Persistent or painful mouth symptoms should be reported.

Regorafenib may interfere with wound healing. If you are planning surgery, dental procedures, or have a non-healing wound, inform your doctor. Regorafenib may need to be temporarily stopped.

Regorafenib should not be used during pregnancy or breastfeeding, as it can harm an unborn baby. Effective contraception is required during regorafenib treatment and for the period advised after stopping regorafenib.

Regorafenib can interact with other medicines, including some antibiotics, antifungals, seizure medicines, and herbal products. Always check with your pharmacist before starting any new medicine while taking regorafenib.

If you miss a dose of regorafenib, skip the missed dose and take the next dose at the usual time. Do not take extra regorafenib to make up for a missed dose.

Regorafenib treatment often involves dose adjustments. This is expected and does not mean regorafenib is failing. Managing side effects early allows many people to continue regorafenib more safely and comfortably.

As your pharmacist, my role is to help you understand how to take regorafenib correctly, recognise side effects early, and know when to seek medical attention. I do not adjust regorafenib doses or manage oncology decisions, but I am here to support you with medicine education and safety.

Regorafenib is a strong targeted cancer medicine that requires close monitoring and active side-effect management. Understanding how regorafenib works and what to expect helps you stay informed, prepared, and actively involved in your regorafenib treatment.